Jubilant Pharmova Q2 net profit falls 74.1%

GreyOak summary

Jubilant Pharmova reported a 74.1% year-on-year decline in consolidated net profit to ₹31.2 crore for Q2 FY27. Revenue rose 20.5% to ₹2,370 crore, but EBITDA margins contracted to 10.2%. The company attributed the profit drop to declines in sterile injectables and radiopharma earnings.